Clinical Trial Update: Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of imipramine for multi-organ bodily distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Somatization Disorder
• Somatoform Disorders

Drugs mentioned

• Imipramine (imipramine)

Snippet

Sponsor: University of Aarhus | Conditions: Somatisation Disorder, Somatoform Disorders | Phase 2 | Status: COMPLETED